Insider Selling: Cardlytics (NASDAQ:CDLX) Insider Sells 40,296 Shares of Stock

Key Points

• Insider Nicholas Hollmeyer Lynton sold 40,296 shares of Cardlytics on April 1 at an average price of $0.99 (~$39,893), reducing his ownership by 19.36% to 167,856 shares (valued at about $166,177).
• Cardlytics shares jumped ~13% to $1.13 on heavy volume, but the company reported a quarterly EPS of ($0.15) that missed estimates, has negative margins and ROE, a market cap of roughly $62.2M, and a consensus analyst rating of "Reduce" with an average price target of $1.75.

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 40,296 shares of the company's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $0.99, for a total value of $39,893.04. Following the transaction, the insider owned 167,856 shares of the company's stock, valued at approximately $166,177.44. This trade represents a 19.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Nicholas Hollmeyer Lynton also recently made the following trade(s):

• On Monday, January 5th, Nicholas Hollmeyer Lynton sold 6,253 shares of Cardlytics stock. The stock was sold at an average price of $1.17, for a total transaction of $7,316.01.

Cardlytics Trading Up 13.0%

NASDAQ:CDLX traded up $0.13 during trading hours on Thursday, hitting $1.13. 2,137,597 shares of the company traded hands, compared to its average volume of 1,043,434. Cardlytics, Inc. has a twelve month low of $0.66 and a twelve month high of $3.28. The firm has a 50-day moving average of $0.90 and a 200 day moving average of $1.34. The stock has a market capitalization of $62.23 million, a price-to-earnings ratio of -0.58 and a beta of 0.91.

Cardlytics (NASDAQ:CDLX - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.08). Cardlytics had a negative return on equity of 370.98% and a negative net margin of 44.36%.The company had revenue of $56.10 million during the quarter, compared to analyst estimates of $54.46 million. Equities research analysts predict that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CDLX has been the subject of a number of research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Cardlytics in a research report on Monday, December 29th. Evercore set a $1.00 target price on Cardlytics in a research note on Friday, March 6th. Finally, Bank of America reaffirmed an "underperform" rating on shares of Cardlytics in a research report on Thursday, March 5th. Two equities research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Reduce" and an average price target of $1.75.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. XTX Topco Ltd boosted its stake in shares of Cardlytics by 143.5% in the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company's stock valued at $141,000 after purchasing an additional 50,663 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of Cardlytics in the 2nd quarter worth about $59,000. Sand Hill Global Advisors LLC acquired a new stake in shares of Cardlytics during the 2nd quarter worth about $35,000. Jane Street Group LLC lifted its holdings in Cardlytics by 263.0% during the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company's stock valued at $267,000 after purchasing an additional 117,687 shares during the last quarter. Finally, Global Retirement Partners LLC lifted its holdings in Cardlytics by 67.3% during the 3rd quarter. Global Retirement Partners LLC now owns 34,800 shares of the company's stock valued at $85,000 after purchasing an additional 14,000 shares during the last quarter. 68.10% of the stock is owned by institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers' online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics' offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.